Appelhans Carolin, Breuckmann Frank, Bastian Andreas, Altmeyer Peter, Kreuter Alexander
Dept, of Dermatology, Ruhr-University Bochum, Gudrunstr, 56, D-44791 Bochum, Germany.
BMC Dermatol. 2004 Nov 8;4(1):17. doi: 10.1186/1471-5945-4-17.
EMO syndrome, defined as a triad including exophthalmus, pretibial myxedema and osteoarthropathia, is a rare condition in patients suffering from hyperthyreosis.
We here describe an interesting case of EMO syndrome associated with unilateral fibromatosis of the hand and an initial stage of generalized myxedema of the skin. To our knowledge a similar case has not yet been described in literature though reports about associated fibromatosis, e.g. located retroperitoneally, already exist. Familiar explanations include its initiation by autoimmune processes or aberrant T-cell cytokine stimulation leading to an overwhelming production of glycosaminoglycans.
Interpreting our case in context with previous reports we conclude that associated fibromatosis induced by autoimmune processes may affect a variety of different localizations and therefore requires careful monitoring. A therapeutical attempt by using UVA1 irridation for pretibial myxedema remained without a satisfying regression.
EMO综合征定义为包括突眼、胫前黏液性水肿和骨关节病的三联征,是甲状腺功能亢进患者中的一种罕见病症。
我们在此描述一例与手部单侧纤维瘤病及皮肤广泛性黏液性水肿初期相关的EMO综合征有趣病例。据我们所知,尽管已有关于相关纤维瘤病(如位于腹膜后的)的报道,但类似病例尚未见文献描述。常见解释包括其由自身免疫过程引发或异常T细胞细胞因子刺激导致糖胺聚糖大量产生。
结合既往报道解读我们的病例,我们得出结论,自身免疫过程诱导的相关纤维瘤病可能影响多种不同部位,因此需要仔细监测。使用UVA1照射治疗胫前黏液性水肿的尝试未取得令人满意的消退效果。